Peripheral Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
150
|
18
|
0.010 |
None |
1.000 |
1 |
1
|
2020 |
2020 |
Malignant neoplasm of mouth
|
group |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
756
|
184
|
0.010 |
None |
1.000 |
1 |
1
|
2020 |
2020 |
Lip and Oral Cavity Carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
734
|
172
|
0.010 |
None |
1.000 |
1 |
1
|
2020 |
2020 |
Fetal Alcohol Spectrum Disorders
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders
|
Disease or Syndrome; Congenital Abnormality
|
46
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
862
|
115
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nicotine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
178
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adenocarcinoma of the gastroesophageal junction
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
32
|
6
|
0.010 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chronic nasopharyngitis
|
disease |
Infections; Respiratory Tract Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Periodontitis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
682
|
116
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma, Lewis Lung
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
188
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Glycosuria
|
phenotype |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
53
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Fetal Alcohol Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Chemically-Induced Disorders
|
Disease or Syndrome
|
89
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Experimental Organism Basal Cell Carcinoma
|
phenotype |
Neoplasms
|
Neoplastic Process
|
437
|
63
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Childhood Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
771
|
25
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
762
|
24
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |